Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.43 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.43 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.43 |
| ▸ | SCN4A | P35499 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28486352 | 1.00 | KMT2A (0.60) | KMT2AMEN1SMN1; SMN2LMNANPSR1 | |
| SCHEMBL14430999 | 0.84 | KMT2A (0.56) | KMT2AMEN1SMN1; SMN2LMNANPSR1 | |
| SCHEMBL28542976 | 0.83 | TSHR (0.41) | KMT2AMEN1SMN1; SMN2LMNANPSR1 | |
| SCHEMBL28542978 | 0.83 | TSHR (0.41) | KMT2AMEN1SMN1; SMN2LMNANPSR1 | |
| SCHEMBL20002160 | 0.83 | KMT2A (0.56) | KMT2AMEN1SMN1; SMN2LMNANPSR1 | |
| SCHEMBL17069031 | 0.82 | NPC1 (0.59) | KMT2AMEN1SMN1; SMN2LMNANPSR1 | |
| SCHEMBL4436777 | 0.81 | SMN1; SMN2 (0.60) | KMT2AMEN1SMN1; SMN2LMNANPSR1 | |
| SCHEMBL28916508 | 0.81 | KMT2A (0.55) | KMT2AMEN1SMN1; SMN2LMNANPSR1 | |
| SCHEMBL28915732 | 0.81 | KMT2A (0.55) | KMT2AMEN1SMN1; SMN2LMNANPSR1 | |
| SCHEMBL18374165 | 0.81 | SMN1; SMN2 (0.60) | KMT2AMEN1SMN1; SMN2LMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111936475-B | Immunomodulator, composition and preparation method thereof | 贝达药业股份有限公司 | 2024-05-10 | — | — | CN | disclosed |
| US-20220119411-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | BETTA PHARMACEUTICALS CO., LTD (CN) | 2022-04-21 | — | — | US | disclosed |
| US-20220119411-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | BETTA PHARMACEUTICALS CO., LTD (CN) | 2022-04-21 | — | — | US | disclosed |
| US-20210040118-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | BETTA PHARMACEUTICALS CO., LTD (CN) | 2021-02-11 | — | — | US | disclosed |
| CN-111936475-A | Immunomodulator, composition and preparation method thereof | 贝达药业股份有限公司 | 2020-11-13 | — | — | CN | disclosed |
| WO-2020011243-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | BETTA PHARMACEUTICALS CO., LTD (CN) | 2020-01-16 | — | — | WO | disclosed |
| WO-2019192506-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | BETTA PHARMACEUTICALS CO., LTD (CN) | 2019-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210040118-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | IL2, IL5, TSLP | KMT2A 4130/4885MEN1 1462/4885SMN1; SMN2 4120/4885 |
| US-20220119411-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | IL2, IL5, TSLP | KMT2A 4130/4885MEN1 1462/4885SMN1; SMN2 4120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.